Skip to main content

Table 2 Baseline characteristics based on baseline visual acuity

From: Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study

  Decimal Visual Acuity
Below 0.5 Above 0.6
N = 58 N = 41
Age 74.5 (±7.9) 71.3 (±10.3)
Sex
 Male 45 (77.6%) 32 (78%)
 Female 13 (22.4%) 9 (22%)
Type of AMD
 AMD 51 (87.9%) 32 (78%)
 PCV 4 (6.9%) 9 (22%)
 RAP 3 (5.2%) .
  1. AMD age-related macular degeneration, PCV polypoidal choroidal vasculopathy, RAP retinal angiomatous proliferation
\